Fintel on MSN7h
Goldman Sachs Downgrades Dynavax Technologies (DVAX)
Fintel reports that on February 11, 2025, Goldman Sachs downgraded their outlook for Dynavax Technologies (NasdaqGS:DVAX) ...
Dynavax stock drops following Goldman Sachs downgrade
Goldman Sachs analyst Paul Choi downgraded the stock from "Neutral" to "Sell," setting a price target of $12, which is ...
Goldman Sachs cuts Dynavax stock rating to sell, target to $12
Goldman Sachs downgraded Dynavax Technologies Corporation (NASDAQ:DVAX) stock from Neutral to Sell, adjusting the price target downward to $12.00 from the previous $15.00. According to InvestingPro ...